# 2025年11月14日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 当统计学的“警报”掩盖了临床问题

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41231267](https://pubmed.ncbi.nlm.nih.gov/41231267)
**期刊：** Intensive care medicine
**PMID：** 41231267
**DOI：** 10.1007/s00134-025-08202-7

### 第一部分 原文与翻译

**英文原标题：** When the sirens of statistics eclipse the clinical question.

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无可用摘要。

### 第二部分 AI 大师评价

根据标题判断，本文很可能是一篇评论性文章或社论，旨在警示研究者和临床医生不应过度依赖或误用统计学方法。文章标题巧妙地将统计学比作“警报”（sirens），暗示其“显著性”结果可能像海妖之歌一样诱人但具有误导性，从而掩盖了研究的核心——即解决真正的临床问题。该文的核心观点在于强调临床相关性的重要性远超单纯的统计学意义，对于推动研究回归临床本质、培养批判性思维具有重要的指导价值。

---

## 2. 脓毒症幸存者亚型与出院后长期死亡率和残疾的关联：一项回顾性队列研究

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41231072](https://pubmed.ncbi.nlm.nih.gov/41231072)
**期刊：** Critical care medicine
**PMID：** 41231072
**DOI：** 10.1097/CCM.0000000000006933

### 第一部分 原文与翻译

**英文原标题：** Association of Sepsis Survivor Subtypes With Long-Term Mortality and Disability After Discharge: A Retrospective Cohort Study.

**英文摘要原文：**
OBJECTIVES: Determine if previously described sepsis survivor subtypes can be applied outside of their derivation cohort using a parsimonious algorithm. Test the association between subtype and the primary outcome of 3-month mortality, and secondary outcomes of readmission, physical function, and health-related quality of life through 1 year of follow-up.

DESIGN: Retrospective cohort study.

SETTING: Participants enrolled in the Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS) trial, a multisite trial in the United States that enrolled patients with sepsis-induced hypotension.

PATIENTS: All participants who were alive on day 28 after enrollment and had nonmissing data for outcome and subtype-defining variables (Charlson Comorbidity Index, length of stay, discharge destination). Participants were retrospectively assigned at time of discharge to one of five previously derived survivor subtypes: low risk, healthy with severe disease, multimorbidity, low functional status, and unhealthy baseline with severe disease.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Of 1563 participants, 1368 were eligible and assigned a subtype. Three-month mortality was 13.1% and varied significantly between subtypes (5.1-45.5%; p < 0.001). In age-adjusted logistic regression, odds ratios for 3-month mortality were 11.1 in the low functional status and 9.7 in the unhealthy baseline with severe illness subtypes, compared with the low-risk subtype (p < 0.001). Participant subtype was a significant predictor of 6- and 12-month EuroQol 5D five level score and limitations in activities of daily living, but not readmission.

CONCLUSIONS: Sepsis survivor subtypes that are readily identifiable at hospital discharge are significantly associated with mortality at 3 months, and patient-important outcomes through 12 months. Using subtypes to predict a patient's risk of adverse outcomes could aid the discharge planning and recovery process.

**中文摘要译文：**
目的：确定先前描述的脓毒症幸存者亚型是否可以使用简约算法应用于其派生队列之外的人群。检验亚型与3个月死亡率这一主要结局，以及长达1年随访期内的再入院、身体功能和健康相关生活质量等次要结局之间的关联。

设计：回顾性队列研究。

地点：参与者来自“脓毒症晶体液放开或血管升压药早期复苏（CLOVERS）试验”，这是一项在美国进行的多中心试验，招募了脓毒症所致低血压患者。

患者：所有在入组后第28天仍然存活，并且结局和亚型定义变量（Charlson合并症指数、住院时长、出院去向）数据无缺失的参与者。在出院时，参与者被回顾性地分配到五个先前派生的幸存者亚型之一：低风险型、健康但病情严重型、多种合并症型、低功能状态型和基线不健康且病情严重型。

干预措施：无。

测量与主要结果：在1563名参与者中，1368名符合条件并被分配了亚型。3个月死亡率为13.1%，且在不同亚型间存在显著差异（5.1-45.5%；p < 0.001）。在经年龄校正的logistic回归分析中，与低风险亚型相比，低功能状态亚型和基线不健康且病情严重亚型的3个月死亡率比值比分别为11.1和9.7（p < 0.001）。参与者亚型是6个月和12个月时欧洲五维健康量表（EuroQol 5D）五水平得分和日常生活活动受限的重要预测因子，但与再入院率无关。

结论：可在出院时轻松识别的脓毒症幸存者亚型与3个月死亡率以及长达12个月的患者重要结局显著相关。利用这些亚型来预测患者发生不良结局的风险，可能有助于出院计划的制定和康复过程的管理。

### 第二部分 AI 大师评价

该研究旨在验证一个简化的脓毒症幸存者分型系统，并评估其预测出院后长期不良结局的能力。研究者通过对一项大型临床试验（CLOVERS）数据的回顾性分析发现，在出院时即可轻松识别的五个幸存者亚型与患者3个月死亡率及长达1年的功能状态和生活质量显著相关。这项研究的创新价值在于，它提供了一个基于临床易得信息（如合并症、住院时长、出院去向）的实用分层工具，有助于临床医生为不同风险的脓毒症患者制定更具个体化的出院计划和康复策略，从而改善患者的长期预后。

---

## 3. 目标试验模拟在重症监护临床研究中的机遇、挑战与未来展望

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41225646](https://pubmed.ncbi.nlm.nih.gov/41225646)
**期刊：** Critical care (London, England)
**PMID：** 41225646
**DOI：** 10.1186/s13054-025-05723-x

### 第一部分 原文与翻译

**英文原标题：** Opportunities, challenges and future perspectives for target trial emulation in critical care clinical research.

**英文摘要原文：**
Target trial emulation (TTE) is a powerful framework for addressing causal questions using observational data. By explicitly designing analyses to mimic a hypothetical randomized trial, TTE enables researchers to more precisely define their research questions, leading to more clinically meaningful conclusions. Its forward-looking design also helps limit common biases, such as immortal time bias and selection bias. Understanding TTE principles is essential not only for researchers working with observational data but also for clinicians who aim to critically interpret the growing number of TTE studies, as well as studies addressing causal questions without explicit use of the TTE framework. In this review, using the timing of switch from controlled to assisted ventilation as a key example, we outline the core assumptions underpinning valid causal inference in TTE: consistency, conditional exchangeability, and positivity. We discuss practical challenges in dynamic critical care settings, including defining a meaningful time zero, handling grace periods, and selecting and properly adjusting for confounders. We also discuss caveats, such as TTE's applicability to non-modifiable interventions, limited applicability for intention-to-treat effects, and the need for high-resolution longitudinal data. Finally, we provide a visual summary linking each trial component to key indicators of high-quality emulation.

**中文摘要译文：**
目标试验模拟（TTE）是利用观察性数据解决因果问题的强大框架。通过明确设计分析以模拟一项假设的随机试验，TTE使研究人员能够更精确地定义其研究问题，从而得出更具临床意义的结论。其前瞻性设计亦有助于限制常见偏倚，如永生时间偏倚和选择偏倚。理解TTE原则不仅对使用观察性数据的研究人员至关重要，也对旨在批判性解读日益增多的TTE研究以及未使用TTE框架明确解决因果问题的研究的临床医生至关重要。在这篇综述中，我们以从控制通气转换至辅助通气的时机为关键范例，概述了支撑TTE中有效因果推断的核心假设：一致性、条件可交换性和正值性。我们讨论了在动态变化的重症监护环境中面临的实际挑战，包括定义有意义的“时间零点”、处理宽限期，以及选择并恰当调整混杂因素。我们还探讨了其局限性，例如TTE对不可改变干预措施的适用性、对意向性治疗效果分析的有限适用性，以及对高分辨率纵向数据的需求。最后，我们提供了一个可视化摘要，将每个试验组成部分与高质量模拟的关键指标联系起来。

### 第二部分 AI 大师评价

本文是一篇方法学综述，旨在系统阐述目标试验模拟（TTE）框架在重症监护临床研究中的应用。文章通过以通气模式转换为例，详细剖析了TTE的核心假设、实施挑战（如定义时间零点、处理混杂因素）及其局限性。该综述为研究者利用观察性数据进行因果推断提供了清晰的路线图，也为临床医生批判性评价相关文献提供了重要参考，对于提升重症领域研究的严谨性与临床转化价值具有重要指导意义。

---

## 4. 第二代裂解素作为治疗铜绿假单胞菌感染的治疗药物

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41222983](https://pubmed.ncbi.nlm.nih.gov/41222983)
**期刊：** Antimicrobial agents and chemotherapy
**PMID：** 41222983
**DOI：** 10.1128/aac.01312-25

### 第一部分 原文与翻译

**英文原标题：** Second-generation lysocins as therapeutics for treating  infections.

**英文摘要原文：**
is a leading cause of nosocomial infections, including pneumonia and urinary tract infections, and the primary cause of morbidity and mortality in cystic fibrosis patients. The emergence of multidrug-resistant strains makes these infections life-threatening. To overcome this challenge, lysocins can be employed as novel antipseudomonals. Lysocins use components of the pyocin antimicrobial system to deliver bacteriophage lysins to their peptidoglycan substrate in . Peptidoglycan cleavage causes membrane destabilization, cytoplasmic leakage, and disruption of the proton motive force, thereby killing the cell. In our previous proof-of-concept study, the PyS2-GN4 lysocin killed only one-third of  strains due to the targeted receptor. This limitation can now be circumvented by engineering second-generation lysocins that bind and translocate through highly conserved -specific receptors. One lysocin, PyS5-I-GN4, uses a single domain from pyocin S5 to deliver the GN4 lysin through the conserved ferric pyochelin transporter, consequently killing 95% of multidrug-resistant clinical isolates tested. Importantly, PyS5-I-GN4 displayed antibiofilm properties and was bactericidal in serum and lung surfactant. Serum inactivation observed for lysins is not seen for lysocins, making this approach more effective for treating systemic Gram-negative bacterial infections. Despite its broadened pseudomonal strain coverage, PyS5-I-GN4 demonstrated narrow-spectrum antibacterial activity toward  only and lacked cytotoxicity toward human cells. A single dose of lysocin was protective and reduced bacteria multiple log-fold in the lungs and secondary organs in a neutropenic murine lung infection model. These findings support lysocins as therapeutics for  and provide insight into designing future constructs for other Gram-negative pathogens.

**中文摘要译文：**
铜绿假单胞菌是导致医院内感染（包括肺炎和尿路感染）的主要原因，也是囊性纤维化患者发病和死亡的首要因素。多重耐药菌株的出现使这些感染具有生命威胁。为应对这一挑战，可采用裂解素作为新型抗铜绿假单胞菌药物。裂解素利用绿脓菌素抗菌系统的组分，将噬菌体裂解酶递送至铜绿假单胞菌的肽聚糖底物。肽聚糖的裂解导致细胞膜失稳、细胞质泄漏和质子动力的破坏，从而杀死细胞。在我们先前的概念验证研究中，由于靶向受体的限制，PyS2-GN4裂解素仅能杀死三分之一的铜绿假单胞菌菌株。现在，通过工程化改造能够结合并转运通过高度保守的铜绿假单胞菌特异性受体的第二代裂解素，这一局限性得以规避。其中一种名为PyS5-I-GN4的裂解素，利用来自绿脓菌素S5的单个结构域，通过保守的脓青素铁转运体递送GN4裂解酶，从而杀死了95%的受试多重耐药临床分离株。重要的是，PyS5-I-GN4在血清和肺表面活性物质中表现出抗生物膜特性和杀菌活性。在裂解素中未观察到传统裂解酶所遇到的血清失活问题，这使得该方法在治疗全身性革兰氏阴性菌感染方面更为有效。尽管PyS5-I-GN4扩大了对铜绿假单胞菌菌株的覆盖范围，但它仅对铜绿假单胞菌表现出窄谱抗菌活性，并且对人体细胞没有细胞毒性。在中性粒细胞减少的小鼠肺部感染模型中，单剂量的裂解素具有保护作用，并使肺部及次级器官中的细菌数量降低了数个对数倍。这些发现支持将裂解素作为治疗铜绿假单胞菌感染的药物，并为未来针对其他革兰氏阴性病原体设计构建体提供了见解。

### 第二部分 AI 大师评价

本研究旨在开发一种新型第二代裂解素（PyS5-I-GN4），以应对多重耐药铜绿假单胞菌的挑战。研究通过工程化改造，将绿脓菌素S5的结构域与GN4裂解酶融合，使其能通过一个高度保守的受体进入细菌，从而克服了第一代药物靶点覆盖率低的局限性。关键发现表明，该药物不仅对高达95%的临床耐药菌株有效，且具备抗生物膜活性、血清稳定性，并在动物模型中展现出强大的体内保护效果和高度的物种特异性。这项工作为开发针对耐药菌的新型精准靶向生物药提供了重要的策略和范例，具有显著的临床转化潜力。

---

## 5. 精通脓毒性休克中血管加压素的床边实践应用

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41222655](https://pubmed.ncbi.nlm.nih.gov/41222655)
**期刊：** Intensive care medicine
**PMID：** 41222655
**DOI：** 10.1007/s00134-025-08204-5

### 第一部分 原文与翻译

**英文原标题：** Mastering the practical application of vasopressin at the bedside in septic shock.

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无可用摘要。

### 第二部分 AI 大师评价

该文献标题表明，这可能是一篇旨在指导临床医生如何在脓毒性休克患者的床边精准应用血管加压素的综述或专家共识。文章的核心价值在于聚焦临床实践，旨在弥合理论知识与复杂多变的床旁决策之间的鸿沟。虽然缺乏摘要信息，无法得知其具体论点，但该主题对于优化危重症患者的血流动力学管理、改善预后具有重要的现实指导意义。

---

## 6. 药物中毒患者的危重症管理

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41222651](https://pubmed.ncbi.nlm.nih.gov/41222651)
**期刊：** Intensive care medicine
**PMID：** 41222651
**DOI：** 10.1007/s00134-025-08176-6

### 第一部分 原文与翻译

**英文原标题：** Critical care management of the patient with pharmaceutical poisoning.

**英文摘要原文：**
Poisonings account for up to 10% of admissions to intensive care units and represent a common yet complex challenge in critical care. While most patients recover with supportive care alone, a significant proportion require targeted interventions and advanced organ support. This state-of-the-art review provides a practical, evidence-based guide to manage pharmaceutical poisoning in the intensive care unit, with emphasis on real-world applicability for intensivists. It highlights toxicant-specific considerations for early resuscitation, structured by the ABCDE approach. Essential principles of the diagnostic workup are also summarized. In addition, the review offers actionable guidance on when and how to escalate care, moving from supportive measures to specific interventions including gastrointestinal decontamination, extracorporeal toxicant elimination, antidote therapy, and rescue strategies such as intravenous lipid emulsion and extracorporeal membrane oxygenation. Key algorithms and decision pathways-such as the diagnostic evaluation, ABCDE-based stabilization, gastrointestinal decontamination, and extracorporeal elimination approaches-are presented with visually structured figures. A comprehensive table provides an overview of the most relevant antidotes used in critical care, including indications and dosing.

**中文摘要译文：**
中毒占重症监护室收治患者的比例高达10%，是危重症医学领域中一个常见而复杂的挑战。虽然大多数患者仅通过支持性治疗即可康复，但仍有相当一部分患者需要靶向干预和高级器官支持。这篇代表当前最高水平的综述为重症监护室中的药物中毒管理提供了实用、基于证据的指南，并强调了对重症医师的真实世界适用性。文章重点阐述了在早期复苏中针对不同毒物的特定注意事项，并采用ABCDE方法进行结构化论述。文中还总结了诊断评估的基本原则。此外，该综述就何时以及如何升级治疗提供了可行的指导，涵盖了从支持性措施到具体干预措施的过渡，包括胃肠道净化、体外毒物清除、解毒剂治疗以及静脉输注脂肪乳和体外膜肺氧合等救援策略。文中通过结构化的图示呈现了关键的算法和决策路径，例如诊断评估、基于ABCDE的稳定化方案、胃肠道净化和体外清除方法的决策流程。最后，文章通过一个全面的表格概述了重症监护中使用的最相关解毒剂，包括其适应症和剂量。

### 第二部分 AI 大师评价

该综述旨在为药物中毒患者的重症监护管理提供一个全面、实用且基于证据的临床指南。文章系统性地梳理了从早期ABCDE复苏、诊断评估到胃肠道净化、体外毒物清除及解毒剂应用等全流程管理要点。其突出价值在于将复杂的决策过程转化为直观的算法和流程图，极大地增强了临床实用性，为重症医师在真实世界中处理此类复杂病例提供了清晰的行动路线图。

---

## 7. 危重症患者治疗后24小时内游离头孢曲松的曲线下面积与C反应蛋白纵向反应之间的关联：一项观察性研究

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41222650](https://pubmed.ncbi.nlm.nih.gov/41222650)
**期刊：** Intensive care medicine
**PMID：** 41222650
**DOI：** 10.1007/s00134-025-08138-y

### 第一部分 原文与翻译

**英文原标题：** The association between unbound ceftriaxone area under the curve in the first 24 treatment hours and longitudinal C-reactive protein response in critically ill patients: an observational study.

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无摘要。

### 第二部分 AI 大师评价

本研究旨在探讨危重症患者使用头孢曲松治疗后24小时内，其体内游离药物浓度（以曲线下面积衡量）与炎症指标C反应蛋白的动态变化之间的关联。该研究通过观察性设计，聚焦于药代动力学/药效动力学（PK/PD）的关键环节，即关注具有生物活性的游离药物部分，这对于优化危重患者的抗生素剂量策略具有重要的临床指导意义。研究结果可能为建立更个体化的头孢曲松给药方案提供依据，从而可能改善治疗效果。尽管摘要缺失限制了对具体发现的了解，但该研究方向对于精准抗感染治疗领域具有前瞻性价值。

---

## 8. 侵袭性脑膜炎球菌病：从昏迷到脓毒性休克

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41222649](https://pubmed.ncbi.nlm.nih.gov/41222649)
**期刊：** Intensive care medicine
**PMID：** 41222649
**DOI：** 10.1007/s00134-025-08182-8

### 第一部分 原文与翻译

**英文原标题：** Invasive meningococcal disease: from coma to septic shock.

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无可用摘要。

### 第二部分 AI 大师评价

由于该文献无可用摘要，无法进行详尽的分析。根据标题推断，本文可能聚焦于侵袭性脑膜炎球菌病的严重临床表现，探讨其从严重神经系统并发症（昏迷）快速进展至循环衰竭（脓毒性休克）的病理生理过程或临床管理。该主题对于重症监护领域的医生具有重要的临床指导价值，强调了对此类凶险感染进行快速诊断和干预的必要性。然而，缺乏摘要使得我们无法了解其具体的研究类型（如病例报告、综述或临床研究）及其核心发现。

---

## 9. 复发性危重症患儿长期功能状态的潜在类别分析

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41222419](https://pubmed.ncbi.nlm.nih.gov/41222419)
**期刊：** Critical care medicine
**PMID：** 41222419
**DOI：** 10.1097/CCM.0000000000006949

### 第一部分 原文与翻译

**英文原标题：** Latent Classes in Long-Term Functional Status in Children With Recurrent Critical Illness.

**英文摘要原文：**
OBJECTIVES: To identify and describe trajectories of functional status in children with repeated PICU admissions and to describe clinical and demographic characteristics of each trajectory.

DESIGN: Retrospective, cross-sectional study.

SETTING: Twenty-four U.S. PICUs participating in the Virtual Pediatric Systems, LLC database.

PATIENTS: Patients younger than 21 years old discharged from an index admission between April 2017 and December 2020, followed through December 2022.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Functional status, a multidimensional marker of a child's physiologic and cognitive status, was measured using the Functional Status Scale (FSS). FSS scores were collected by trained abstractors to reflect pre-illness baseline and status at PICU discharge for each encounter. We performed latent trajectory analysis to examine longitudinal patterns in patient FSS categories and identify trajectory classes, with classes selected by the minimum Bayesian Information Criterion. We performed Kruskal-Wallis rank-sum test and chi-square testing to assess differences between groups. The analytic cohort included 6038 children with greater than 1 PICU encounter. Using a linear trajectory model, we identified six latent classes: three stable over time (good [46.6%], moderate [18.7%], and severe dysfunction [15.5%]), two with worsening over time (good/mild dysfunction with significant decline [7.9%], good/mild dysfunction with moderate decline [5.7%]), and one with improvement over time (mild dysfunction with improvement [5.6%]). In univariable analysis, trajectory classes differed based on age, race and ethnicity, diagnosis category, procedural exposure, severity of illness, and length of stay for the index admission. These associations were also present when assessed using multinomial regression and random forest classification.

CONCLUSIONS: In this multi-institutional database study using FSS scores to describe a contemporary, heterogeneous patient population with recurrent PICU-based observations of functional status, we identified six classes of outcome trajectories with different clinical and demographic characteristics.

**中文摘要译文：**
目的: 识别并描述反复入住PICU（儿科重症监护室）的儿童功能状态的轨迹，并阐明各类轨迹的临床及人口统计学特征。

设计: 回顾性、横断面研究。

地点: 参与Virtual Pediatric Systems, LLC数据库的24个美国PICU。

患者: 年龄小于21岁，在2017年4月至2020年12月期间因首次入院（index admission）而出院，并随访至2022年12月的患者。

干预措施: 无。

测量与主要结果: 使用功能状态量表（FSS）测量功能状态，该量表是评估儿童生理和认知状态的多维标志物。由经过培训的数据提取员收集FSS评分，以反映每次入院前的基线水平和出院时的状态。我们采用潜在轨迹分析来检验患者FSS类别的纵向模式并识别轨迹类别，类别选择基于最小贝叶斯信息准则。我们使用Kruskal-Wallis秩和检验和卡方检验来评估组间差异。分析队列包括6038名有超过一次PICU入院经历的儿童。通过线性轨迹模型，我们识别出六个潜在类别：三个随时间保持稳定（功能良好[46.6%]、中度功能障碍[18.7%]和重度功能障碍[15.5%]），两个随时间恶化（功能良好/轻度障碍但显著下降[7.9%]、功能良好/轻度障碍但中度下降[5.7%]），以及一个随时间改善（轻度功能障碍但有改善[5.6%]）。在单变量分析中，不同轨迹类别在年龄、种族与民族、诊断类别、手术暴露、疾病严重程度以及首次入院的住院时长方面存在差异。当使用多项回归和随机森林分类进行评估时，这些关联同样存在。

结论: 在这项多中心数据库研究中，我们使用FSS评分来描述具有反复PICU功能状态观察记录的当代异质性患者群体，并识别出六类具有不同临床和人口统计学特征的结局轨迹。

### 第二部分 AI 大师评价

本研究利用大型多中心数据库，创新性地采用潜在轨迹分析方法，旨在揭示反复入住PICU的危重症患儿其长期功能状态的动态变化模式。研究成功识别出六种不同的结局轨迹，包括稳定、恶化及改善三类，并发现这些轨迹与患儿的基线特征、疾病严重程度及诊疗情况显著相关。该发现不仅深化了对这一高危群体长期预后的理解，更为临床早期识别高风险患-儿、制定个体化康复策略提供了重要的数据支持，具有显著的临床指导价值。

---

## 10. 实时自动化临床恶化警报与触发系统对成年普通病房患者临床结局的影响：一项系统综述与荟萃分析

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41222414](https://pubmed.ncbi.nlm.nih.gov/41222414)
**期刊：** Critical care medicine
**PMID：** 41222414
**DOI：** 10.1097/CCM.0000000000006960

### 第一部分 原文与翻译

**英文原标题：** Effects of Real-Time Automated Clinical Deterioration Alert and Trigger Systems on Clinical Outcomes in Adult General Ward Patients: A Systematic Review and Meta-Analysis.

**英文摘要原文：**
OBJECTIVES: Real-time automated alert and trigger systems that notify clinical staff beyond the patient's assigned bedside nurse are increasingly used to improve the recognition and response to clinical deterioration in hospital wards. This review evaluated their effects on clinical outcomes in adult general ward patients.

DATA SOURCES: Seven electronic databases were searched from inception to April 1, 2024, supplemented with citation tracking.

STUDY SELECTION: Two sets of reviewers independently screened for comparative studies assessing automated clinical deterioration alert and trigger systems vs. conventional manual escalation processes.

DATA EXTRACTION: Two sets of reviewers extracted data. Primary outcomes were hospital mortality and in-hospital cardiac arrest. Secondary outcomes included unplanned ICU transfers, and hospital and ICU length of stay. Data were pooled using random-effects meta-analysis.

DATA SYNTHESIS: Eighteen studies (n = 349,818) were included: two randomized controlled trials (RCTs), 15 before-and-after designs, and one quasi-experimental study. All studies had at least moderate risk of bias. The main meta-analysis included nine studies (n = 58,632) involving alert-eligible cohorts (i.e., patients meeting alert thresholds). Based on two before-and-after studies, automated alert and trigger systems were associated with a significant reduction in-hospital cardiac arrests (risk ratio [RR], 0.60; 95% CI, 0.43-0.85; p = 0.004). No significant reduction in hospital mortality was observed (RR, 0.80; 95% CI, 0.62-1.05; p = 0.09), based on pooled data from RCTs and before-and-after studies. ICU length of stay was also significantly reduced, based on one RCT and one before-and-after study. No significant effects were found for hospital length of stay or unplanned ICU transfers in either alert-eligible or all-admission cohorts.

CONCLUSIONS: Real-time clinical deterioration automated alert and trigger systems are associated with reduced in-hospital cardiac arrests and may offer mortality benefits when integrated into structured escalation pathways. Further high-quality trials are needed to confirm these findings and optimize system design.

**中文摘要译文：**
目的: 实时自动化警报与触发系统能够通知患者主管床位护士以外的临床人员，其应用日益广泛，旨在提升医院病房中对临床恶化的识别与响应能力。本综述旨在评估这类系统对成年普通病房患者临床结局的影响。

数据来源: 检索了七个电子数据库，时间范围自建库至2024年4月1日，并辅以引文追踪。

研究筛选: 两组评审员独立筛选了评估自动化临床恶化警报与触发系统与传统人工上报流程效果的比较性研究。

数据提取: 两组评审员提取了数据。主要结局指标为住院死亡率和院内心脏骤停率。次要结局指标包括非计划性ICU转入、住院时长和ICU住院时长。数据采用随机效应模型进行荟萃分析。

数据综合: 共纳入十八项研究（n = 349,818），包括两项随机对照试验（RCTs）、十五项前后对照设计研究和一项准实验研究。所有研究均存在至少中等偏倚风险。主要荟萃分析纳入了九项涉及符合警报条件队列（即患者达到警报阈值）的研究（n = 58,632）。基于两项前后对照研究的结果，自动化警报与触发系统与院内心脏骤停率的显著降低相关（风险比 [RR] 为 0.60；95% CI, 0.43-0.85；p = 0.004）。基于随机对照试验和前后对照研究的汇总数据，未观察到住院死亡率有显著降低（RR 为 0.80；95% CI, 0.62-1.05；p = 0.09）。基于一项随机对照试验和一项前后对照研究，ICU住院时长也显著缩短。在符合警报条件的队列或所有入院患者队列中，均未发现对住院时长或非计划性ICU转入有显著影响。

结论: 实时临床恶化自动警报与触发系统与院内心脏骤停率的降低相关，并且当其整合到结构化的上报流程中时，可能带来死亡率方面的益处。未来需要更多高质量的试验来证实这些发现并优化系统设计。

### 第二部分 AI 大师评价

本研究通过系统综述与荟萃分析，全面评估了实时自动化临床恶化警报系统在普通病房的应用效果。研究的关键发现是，这类系统能显著降低院内心脏骤停的发生率并缩短ICU住院时长，但对住院死亡率的改善尚未达到统计学显著性。这项工作为医疗机构部署类似预警系统提供了重要的循证依据，凸显了其在预防急性恶性事件中的价值，并指明了未来需通过更高质量的随机对照试验来验证其对死亡率的潜在益处并优化系统整合方案。

---

## 11. 院外心脏骤停患者接受体外心肺复苏后的急性肾损伤

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41222408](https://pubmed.ncbi.nlm.nih.gov/41222408)
**期刊：** Critical care medicine
**PMID：** 41222408
**DOI：** 10.1097/CCM.0000000000006946

### 第一部分 原文与翻译

**英文原标题：** Acute Kidney Injury After Extracorporeal Cardiopulmonary Resuscitation for Out-of-Hospital Cardiac Arrest.

**英文摘要原文：**
OBJECTIVES: Acute kidney injury (AKI) occurs frequently in ICUs and is associated with poor outcomes. However, little is known about AKI in patients undergoing extracorporeal cardiopulmonary resuscitation (ECPR) for out-of-hospital cardiac arrest (OHCA). Our aims were to identify real-world data on AKI in the early phase of intensive care, examine the relationship between AKI and outcomes, and identify factors contributing to the occurrence of AKI in patients undergoing ECPR for OHCA.

DESIGN: A secondary analysis of the Study of Advanced life support for Ventricular fibrillation with Extracorporeal circulation in Japan (SAVE-J II study), a retrospective multicenter study involving patients 18 years old or older who experienced OHCA and received ECPR between 2013 and 2018.

SETTING: Thirty-six ICUs that participated in the SAVE-J II study in Japan.

PATIENTS: Adult patients with OHCA of presumed cardiac etiology who received ECPR and were admitted to the ICU.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: In this study, AKI was defined based on the Kidney Disease: Improving Global Outcomes criteria with regard to serum creatinine level during the 4 days after ICU admission. The primary outcome was in-hospital mortality, and the secondary outcome was an unfavorable neurologic outcome (Cerebral Performance Category scores of 3-5 at discharge). Among the 943 patients, AKI occurred in 66.9% (n = 631). Multivariable analysis showed that AKI was significantly associated with in-hospital mortality (odds ratio [OR], 4.15; 95% CI, 3.05-5.66; p < 0.001) and with unfavorable neurologic outcomes (OR, 3.43; 95% CI, 2.42-4.87; p < 0.001). Furthermore, age, time course, pH level at hospital arrival, creatinine level at hospital admission, and blood pressure on ICU admission were significantly associated with the occurrence of AKI.

CONCLUSIONS: This large cohort study revealed that AKI was commonly observed during the early phase after ECPR for OHCA and was associated with in-hospital mortality and unfavorable neurologic outcomes.

**中文摘要译文：**
目的：急性肾损伤（AKI）在ICU中频繁发生，并与不良预后相关。然而，关于院外心脏骤停（OHCA）患者接受体外心肺复苏（ECPR）后发生AKI的情况，我们知之甚少。本研究旨在获取重症监护早期阶段AKI的真实世界数据，探讨AKI与预后之间的关系，并确定导致OHCA患者接受ECPR后发生AKI的促成因素。

设计：本研究是对日本“心室颤动体外循环高级生命支持研究”（SAVE-J II研究）的二次分析，该研究是一项回顾性多中心研究，纳入了2013年至2018年间经历OHCA并接受ECPR的18岁及以上患者。

地点：日本参与SAVE-J II研究的36家ICU。

患者：因推测为心源性的OHCA接受ECPR并入住ICU的成年患者。

干预措施：无。

测量指标与主要结果：本研究中，AKI的定义基于“改善全球肾脏病预后组织”标准，并参考ICU入院后4天内的血清肌酐水平。主要结局为院内死亡率，次要结局为不良神经系统预后（出院时脑功能分级评分为3-5分）。在943名患者中，66.9%（n = 631）发生了AKI。多变量分析显示，AKI与院内死亡率（比值比[OR]，4.15；95% CI，3.05-5.66；p < 0.001）和不良神经系统预后（OR，3.43；95% CI，2.42-4.87；p < 0.001）显著相关。此外，年龄、时间进程、入院时pH值、入院时肌酐水平以及ICU入院时血压与AKI的发生显著相关。

结论：这项大型队列研究表明，AKI在OHCA患者接受ECPR后的早期阶段普遍发生，并与院内死亡率及不良神经系统预后相关。

### 第二部分 AI 大师评价

该研究是一项基于日本大型多中心注册数据（SAVE-J II）的回顾性分析，聚焦于院外心脏骤停（OHCA）后接受体外心肺复苏（ECPR）的患者中急性肾损伤（AKI）的发生率、预后影响及危险因素。研究关键发现，此类患者中AKI的发生率高达66.9%，并且AKI是院内死亡率和不良神经系统预后的强独立预测因子。本研究的价值在于，它利用大规模真实世界数据，首次系统性地揭示了ECPR这一前沿抢救措施下AKI的严峻性及其对患者结局的重大影响，为临床早期风险预警和制定肾脏保护策略提供了重要依据。

---

速递结束，祝您工作愉快！